{"count":43797,"next":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=15080&ordering=-accession","previous":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=15040&ordering=-accession","results":[{"accession":"CLO:0027948","name":"GM20184 cell","definition":"[' DEAFNESS, AUTOSOMAL RECESSIVE 28; DFNB28 TRIO- AND F-ACTIN-BINDING PROTEIN; TRIOBP']","term_type":"cell line"},{"accession":"CLO:0027947","name":"ND00734 cell","definition":"[\" PARKINSON'S DISEASE PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES\"]","term_type":"cell line"},{"accession":"CLO:0027946","name":"ND00733 cell","definition":"[' ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL']","term_type":"cell line"},{"accession":"CLO:0027945","name":"GM20182 cell","definition":"[' DEAFNESS, AUTOSOMAL RECESSIVE 28; DFNB28 TRIO- AND F-ACTIN-BINDING PROTEIN; TRIOBP']","term_type":"cell line"},{"accession":"CLO:0027944","name":"GM20192 cell","definition":"[' DEAFNESS, AUTOSOMAL RECESSIVE 49; DFNB49 MARVEL DOMAIN-CONTAINING PROTEIN 2; MARVELD2']","term_type":"cell line"},{"accession":"CLO:0027943","name":"ND00737 cell","definition":"[\" YOUNG ONSET PARKINSON'S DISEASE; AFFECTED INDIVIDUALS PARKINSON'S DISEASE\"]","term_type":"cell line"},{"accession":"CLO:0027942","name":"ND00736 cell","definition":"[' POPULATION/CONVENIENCE CONTROL']","term_type":"cell line"},{"accession":"CLO:0027941","name":"GM20191 cell","definition":"[' DEAFNESS, AUTOSOMAL RECESSIVE 49; DFNB49 MARVEL DOMAIN-CONTAINING PROTEIN 2; MARVELD2']","term_type":"cell line"},{"accession":"CLO:0027940","name":"GM20190 cell","definition":"[' DEAFNESS, AUTOSOMAL RECESSIVE 49; DFNB49 MARVEL DOMAIN-CONTAINING PROTEIN 2; MARVELD2']","term_type":"cell line"},{"accession":"CLO:0027939","name":"ND00740 cell","definition":"[\" PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES PARKINSON'S DISEASE\"]","term_type":"cell line"},{"accession":"CLO:0027938","name":"GM20189 cell","definition":"[' DEAFNESS, AUTOSOMAL RECESSIVE 49; DFNB49 MARVEL DOMAIN-CONTAINING PROTEIN 2; MARVELD2']","term_type":"cell line"},{"accession":"CLO:0027937","name":"ND00739 cell","definition":"[' ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL']","term_type":"cell line"},{"accession":"CLO:0027936","name":"ND00744 cell","definition":"[\" PARKINSON'S DISEASE\"]","term_type":"cell line"},{"accession":"CLO:0027935","name":"ND00742 cell","definition":"[' ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL']","term_type":"cell line"},{"accession":"CLO:0027934","name":"ND00745 cell","definition":"[' SPOUSAL CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL']","term_type":"cell line"},{"accession":"CLO:0027933","name":"GM20173 cell","definition":"[' MARVEL DOMAIN-CONTAINING PROTEIN 2; MARVELD2 DEAFNESS, AUTOSOMAL RECESSIVE 49; DFNB49']","term_type":"cell line"},{"accession":"CLO:0027932","name":"GM20172 cell","definition":"[' MARVEL DOMAIN-CONTAINING PROTEIN 2; MARVELD2 DEAFNESS, AUTOSOMAL RECESSIVE 49; DFNB49']","term_type":"cell line"},{"accession":"CLO:0027931","name":"ND00707 cell","definition":"[' NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL POPULATION/CONVENIENCE CONTROL']","term_type":"cell line"},{"accession":"CLO:0027930","name":"ND00708 cell","definition":"[\" PARKINSON'S DISEASE YOUNG ONSET PARKINSON'S DNA PANEL; AFFECTED INDIVIDUALS\"]","term_type":"cell line"},{"accession":"CLO:0027929","name":"ND00705 cell","definition":"[\" PARKINSON'S DISEASE PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES\"]","term_type":"cell line"}]}